CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY
批准号:
6300102
负责人:
MICHAEL ANDREEFF
金额:
$33.23万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2000-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Automated Cytometry and Cell Sorter Laboratory/Confocal Microscopy and
Image Analysis Facility provides cellular analysis to investigators with
peer-reviewed grants at M.D. Anderson Cancer Center. The facility develops
and provides cutting-edge techniques in single-cell analysis. Cell
phenotyping, proliferation, and apoptosis assays have been established and
modified as needed for multi-parameter analysis. Immunophenotypic analysis
was combined with assays of intracellular proteins related to apoptosis
(bcl-2, BAG-1, Bcl-Xl, p53, Rb, and fas), proliferation and membrane lipid
asymmetry. Quantitation of cellular antigens allow determination of
antibody binding capacity per cell. Very rare events and progenitor cell
subpopulations have been detected and isolated by three-laser
excitation/eight-parameter fluorescence-activated cell sorting (FACS) for
subsequent analysis by molecular cytogenetics and other molecular
techniques. Acquisition of a high-speed cell sorter and a laser-scanning
microscope will provide state-of-the-art isolation and analysis. Laser
confocal microscopy has been used extensively, and so the acquisition of
a second instrument is necessary. By using a charge coupled-device (CCD)-
based image analysis system, a method for image capture in perfect
registration was developed and has been used extensively for molecular
cytogenetics fluorescence in situ hybridization (FISH) and comparative
genomic hybridization (CGH). FISH has also been combined with the
apoptosis assay to detect apoptosis in normal and leukemic cells. The
number, phenotype, and proliferation of minimal residual disease cells
with abnormalities amenable to FISH analysis can be determined at levels
of as few as one malignant cell in 30,000 normal cells. Methods to detect
transgene expression in cells have been established using beta-
galactosidase (beta-gal), nerve growth factor receptor (NGF-R), and green
fluorescent protein. The Facility has served 26 investigators with peer-
reviewed grants who used the laser confocal microscope for 1,797 and the
FACS facility for 1,970 hours last year, a 33% increase over the last 2
years. The Core has continuously developed new methodology to suit the
evolving needs of its users.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10356325
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10550265
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:10663157
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:9806956
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia
-
批准号:8499746
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2013
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:7897533
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:8056055
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Microenvironment / Leukemia Cell Interactions in CML
-
批准号:8000073
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma
-
批准号:7715218
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:7936811
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:8324135
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia
-
批准号:7468678
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Flow Cytometry
-
批准号:7695941
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Treatment of Metastatic Breast Cancer with Gene Modified Mesenchymal Stem Cells
-
批准号:7737051
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Fluorescence-Activated Cell Sorting (FACS) and Molecular Cytogenetics (FISH)
-
批准号:7270271
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Regulators of Apoptosis in AML
-
批准号:7270264
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6649746
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6796771
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6470779
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY
-
批准号:6481853
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2001
-
负责人:MICHAEL ANDREEFF
-
依托单位: